Loading clinical trials...

A Study of Remote Ischaemic Preconditioning in Patients With Atherosclerosis Undergoing Vascular Surgery | Clinical Trials | Clareo Health

COMPLETEDNA

A Study of Remote Ischaemic Preconditioning in Patients With Atherosclerosis Undergoing Vascular Surgery

NCT02689414•Tartu University Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the effect of preoperative remote ischaemic preconditioning (RIPC) on organ damage and the functional characteristics of arteries in patients undergoing vascular surgery. In addition, we investigate the connection between RIPC and changes in the functional characteristics of arteries and low molecular weight metabolites.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients who are willing to give full informed consent for participation and
•who are undergoing open abdominal aortic aneurysm repair or
•who are undergoing endovascular aortic aneurysm repair or
•who are undergoing lower limb revascularization surgery or
•who are undergoing carotid endarterectomy

Exclusion Criteria

•patients under age of 18
•patients who are pregnant
•patients with known malignancy during last 5 years
•patients with permanent atrial fibrillation or flutter
•patients with symptomatic upper limb atherosclerosis
•patients who require home oxygen therapy
•patients with eGFR \< 30 ml/min/1.73 m2, measured preoperatively
•patients who have had myocardial infarction during last month
•patients who have had upper limb vein thrombosis
•patients who have undergone vascular surgery in the axillary region
+1 more criteria

Locations (1)

Tartu University Hospital

Tartu, Tartu County, Estonia

Key Dates

Start Date

January 1, 2016

Primary Completion Date

February 8, 2018

Completion Date

February 1, 2019

Last Updated

February 28, 2018

Enrollment

ACTUAL participants

Conditions

Abdominal Aortic AneurysmPeripheral Artery DiseaseCarotid Artery Stenosis

Interventions

Remote ischaemic preconditioning

PROCEDURE

Control to RIPC

PROCEDURE

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

NCT06212271

Peripheral Artery Disease

View study

RECRUITING

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

NCT07283289

Peripheral Artery Disease

View study

RECRUITINGEARLY_PHASE1

PET Imaging of MMP Activation in AAA: Clinical Component

NCT07473102

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Remote Ischaemic Preconditioning in Patients With Atherosclerosis Undergoing Vascular Surgery

Inclusion Criteria

Exclusion Criteria

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

PET Imaging of MMP Activation in AAA: Clinical Component

Terumo Aortic Global Endovascular Registry

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft